Impact Investment Profile: SharePractice

Please note the publish date of this blog. Financial information, market conditions, and other data mentioned in this post may no longer be accurate or relevant.

A portfolio company of Better Ventures
sharepractice

Over 5,000 doctors are using SharePractice at the point of care to find treatments for many types of diagnoses. Physicians and medical practitioners rank and comment on thousands of drugs, herbs and supplements in SharePractice so the information is current, complete and peer-sourced.

SharePractice was founded by Dr. Andrew Brandeis and is operated by physicians and engineers on a mission to provide the best treatments for every medical disorder in the most efficient way.

SharePractice is a collaborative clinical reference for doctors. After a doctor makes a diagnosis, a treatment is then recommended. Usually, doctors will consult research, a reference book or a medical resource to find the best course. However, SharePractice does not believe these sources to be adequate because their funding comes from pharmaceutical corporations and insurance companies or from universities where findings are slow to publish.

SharePractice pulls together information from multiple medical databases and contains thousands of diagnoses. Doctors can drill into a specific diagnosis to see the various ways other doctors have treated it. Every treatment is ranked by up-voting or down-voting from the community, and doctors who regularly contribute popular treatments have greater weight within the group. Specialists commenting on their area of expertise also rise to the top. The system will ultimately have filters for qualifiers and “co-morbidities,” which means that recommendations can take age, gender, chronic disease and other factors into account. Some 3,500 crowdsourced treatments have been posted, covering 80% of the most common patient diagnoses. In the coming weeks, SharePractice will add every FDA-approved treatment for these diagnoses.

Better Ventures Fund II is a portfolio company of Abacus Impact Fund 2013, LP.

Disclosure

Abacus Wealth Partners, LLC is an SEC registered investment adviser. SEC registration does not constitute an endorsement of Abacus Wealth Partners, LLC by the SEC nor does it indicate that Abacus Wealth Partners, LLC has attained a particular level of skill or ability. This material prepared by Abacus Wealth Partners, LLC is for informational purposes only and is accurate as of the date it was prepared. It is not intended to serve as a substitute for personalized investment advice or as a recommendation or solicitation of any particular security, strategy or investment product. Advisory services are only offered to clients or prospective clients where Abacus Wealth Partners, LLC and its representatives are properly licensed or exempt from licensure. No advice may be rendered by Abacus Wealth Partners, LLC unless a client service agreement is in place. This material is not intended to serve as personalized tax, legal, and/or investment advice since the availability and effectiveness of any strategy is dependent upon your individual facts and circumstances. Abacus Wealth Partners, LLC is not an accounting or legal firm. Please consult with your tax and/or legal professional regarding your specific tax and/or legal situation when determining if any of the mentioned strategies are right for you.

Please Note: Abacus does not make any representations or warranties as to the accuracy, timeliness, suitability, and completeness, or relevance of any information prepared by an unaffiliated third party, whether linked to Abacus’ website or blog or incorporated herein, and takes no responsibility for any such content. All such information is provided solely for convenience purposes only and all users thereof should be guided accordingly.

For more information about Abacus and this article, please read these important disclosures

Share:

What’s your financial archetype?

Simplify your life with a plan

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.